...
首页> 外文期刊>Clinical hemorheology and microcirculation >Nifedipine effect on red cell rheological properties in patients with systemic scleroderma.
【24h】

Nifedipine effect on red cell rheological properties in patients with systemic scleroderma.

机译:硝苯地平对全身性硬皮病患者红细胞流变特性的影响。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Systemic scleroderma is an autoimmune disease, due to a connective tissue alteration characterized by extracellular matrix increase in the skin and internal organs. It is already known that the Raynaud's phenomenon and the microcapillary obliteration lead to ischemia and peripheral tissue injury. The ischemia-reperfusion phenomenon releases free radicals, that react with red blood cells (RBCs) membrane components originating lipid peroxidation and impairment of the ATP-Ca(++) pump, two possible mechanisms responsible of disease pathogenesis. Nifedipine is a Ca(++)-channel antagonist that has been used for a long time in Raynaud's phenomenon treatment. In the present study we were able to demonstrate that erythrocyte deformability and two other related variables such as membrane fluidity and osmotic fragility improve significantly with nifedipine therapy. It is likely that nifedipine inhibiting cytoplasmic calcium accumulation could restore some red blood cell membrane properties.
机译:系统性硬皮病是一种自身免疫性疾病,是由于结缔组织改变,其特征是皮肤和内部器官的细胞外基质增加。已知雷诺现象和微毛细血管闭塞会导致局部缺血和周围组织损伤。缺血-再灌注现象释放自由基,自由基与红细胞(RBC)膜成分发生反应,导致脂质过氧化和ATP-Ca(++)泵受损,这是造成疾病发病机理的两种可能机制。硝苯地平是一种Ca(++)通道拮抗剂,已在雷诺现象治疗中长期使用。在本研究中,我们能够证明硝苯地平治疗可显着改善红细胞变形性和其他两个相关变量,例如膜流动性和渗透性脆性。硝苯地平抑制细胞质钙积累可能恢复一些红细胞膜特性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号